186 related articles for article (PubMed ID: 33454590)
1. Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome.
Garg A; Rocha M; Starr M; Ortega-Gutierrez S
J Neurol Sci; 2021 Feb; 421():117312. PubMed ID: 33454590
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study.
Patel SD; Topiwala K; Saini V; Patel N; Pervez M; Al-Mufti F; Hassan AE; Khandelwal P; Starke RM
J Neurol; 2021 Feb; 268(2):632-639. PubMed ID: 32894331
[TBL] [Abstract][Full Text] [Related]
3. Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome.
Garg A; Starr M; Rocha M; Ortega-Gutierrez S
J Neurol; 2021 Aug; 268(8):3020-3025. PubMed ID: 33646329
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms.
Topcuoglu MA; Singhal AB
Stroke; 2016 Jul; 47(7):1742-7. PubMed ID: 27272485
[TBL] [Abstract][Full Text] [Related]
5. Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) - A systematic review.
Kaufmann J; Buecke P; Meinel T; Beyeler M; Scutelnic A; Kaesmacher J; Mujanović A; Dobrocky T; Arsany H; Peters N; Z'Graggen W; Jung S; Seiffge D
Eur J Neurol; 2024 May; 31(5):e16246. PubMed ID: 38470001
[TBL] [Abstract][Full Text] [Related]
6. Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome: analysis of the National Inpatient Sample.
Lopez-Arevalo H; Romero Noboa ME; Joseph D; Edigin E; Arora S; Manadan A
Clin Rheumatol; 2022 Aug; 41(8):2467-2473. PubMed ID: 35411414
[TBL] [Abstract][Full Text] [Related]
7. Misdiagnosis of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome in the Emergency Department.
Liberman AL; Zhang C; Parikh NS; Salehi Omran S; Navi BB; Lappin RI; Merkler AE; Kaiser JH; Kamel H
J Am Heart Assoc; 2023 Oct; 12(19):e030009. PubMed ID: 37750568
[TBL] [Abstract][Full Text] [Related]
8. Re: Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome (Garg et al., Volume 421, 117312, February 15, 2021).
Singhal AB
J Neurol Sci; 2021 May; 424():117427. PubMed ID: 33810880
[No Abstract] [Full Text] [Related]
9. The prevalence of non-contrast CT imaging abnormalities in reversible cerebral vasoconstriction syndrome: A systematic review and meta-analysis.
Gotesman RD; Niznick N; Dewar B; Fergusson DA; Mallick R; Shorr R; Shamy M; Dowlatshahi D
PLoS One; 2024; 19(3):e0295558. PubMed ID: 38466700
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis.
Patel SD; Topiwala K; Otite Oliver F; Saber H; Panza G; Mui G; Liebeskind DS; Saver JL; Alberts M; Ducros A
Stroke; 2021 Dec; 52(12):3970-3977. PubMed ID: 34470494
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors.
Ducros A; Fiedler U; Porcher R; Boukobza M; Stapf C; Bousser MG
Stroke; 2010 Nov; 41(11):2505-11. PubMed ID: 20884871
[TBL] [Abstract][Full Text] [Related]
12. Reply to the letter to the editor regarding "predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome".
Garg A; Ortega-Gutierrez S
J Neurol Sci; 2021 May; 424():117429. PubMed ID: 33867163
[No Abstract] [Full Text] [Related]
13. Reversible cerebral vasoconstriction syndrome identification of prognostic factors.
Robert T; Kawkabani Marchini A; Oumarou G; Uské A
Clin Neurol Neurosurg; 2013 Nov; 115(11):2351-7. PubMed ID: 24021453
[TBL] [Abstract][Full Text] [Related]
14. Reversible Cerebral Vasoconstriction Syndrome.
Bernard KR; Rivera M
J Emerg Med; 2015 Jul; 49(1):26-31. PubMed ID: 25858343
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature.
Tark BE; Messe SR; Balucani C; Levine SR
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2296-300. PubMed ID: 25156786
[TBL] [Abstract][Full Text] [Related]
16. Transcranial Doppler findings in reversible cerebral vasoconstriction syndrome.
Hathidara M; Patel NH; Flores A; Cabrera Y; Cabrera F; Koch S
J Neuroimaging; 2022 Mar; 32(2):345-351. PubMed ID: 34784094
[TBL] [Abstract][Full Text] [Related]
17. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage.
Muehlschlegel S; Kursun O; Topcuoglu MA; Fok J; Singhal AB
JAMA Neurol; 2013 Oct; 70(10):1254-60. PubMed ID: 23939614
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome.
Boitet R; de Gaalon S; Duflos C; Marin G; Mawet J; Burcin C; Roos C; Fiedler U; Bousser MG; Ducros A
Stroke; 2020 Feb; 51(2):670-673. PubMed ID: 31842705
[TBL] [Abstract][Full Text] [Related]
19. Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome.
Garg A; Starr M; Rocha M; Ortega-Gutierrez S
Neurology; 2021 Jun; 96(24):e2912-e2919. PubMed ID: 33952654
[TBL] [Abstract][Full Text] [Related]
20. Reversible cerebral vasoconstriction syndrome in association with fingolimod use.
Belliston S; Sundararajan J; Hammond N; Newell K; Lynch S
Int J Neurosci; 2017 Sep; 127(9):831-834. PubMed ID: 27819760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
